Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Forecasts Single-Digit Revenue Increase in 2009

NEW YORK (GenomeWeb News) — Caliper Life Sciences said today it expects its fourth-quarter 2008 revenues to be $36.5 million, near the upper end of its previous guidance for the quarter of $34 million to $37 million, but 9 percent lower than revenues for the year-ago quarter of $40.3 million.

The company said that it expects to post $133.9 million in full-year 2008 revenue, approximately 5 percent lower than its full-year 2007 revenues of $140.7 million.

During the fourth quarter, Caliper sold its Pharmaceutical Development & Quality and AutoTrace product lines for a total of around $21 million. The company said today that 2008 pro forma revenue, which reflects the divestiture of those product lines, is expected to be approximately $34.6 million for the fourth quarter and $122.8 million for the full year.

For 2009, Caliper currently expects total revenue to increase around 4 percent to 7 percent over 2008 pro forma revenue, with the growth primarily occurring in the second half of the year. In its preliminary revenue statement, the company cited "currency headwinds" as a key factor for its estimates.

The company noted that these financial results are preliminary and are subject to change.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.